H-1,4-trans-ACHC-OMe*HCl

H-1,4-trans-ACHC-OMe*HCl is a hydrochloride salt of a chiral, trans-configured amino acid derivative presented as a methyl ester, where the side chain contains a cyclic, allylic-like carbon framework (ACHC) that preserves defined stereochemistry at the amino-bearing center. The molecule combines an esterified carboxylate functionality with a protonated amine under salt conditions, enabling controlled peptide coupling after conversion to an appropriate N-protected form. The trans relationship in the side-chain stereochemistry can influence conformational bias in downstream peptide analogs and peptidomimetics, while the ester group supports ester-to-amide or ester-to-activated-acid transformations during synthetic sequence design. As an amino acid ester hydrochloride, the compound typically participates as a chiral intermediate for protected amino acid synthesis, stereochemically defined building block preparation, and subsequent functional group interconversions.

1. Peptide Synthesis

H-1,4-trans-ACHC-OMe*HCl supports peptide construction workflows by serving as a chiral amino acid ester precursor that can be converted into an N-protected amino acid derivative for amide bond formation. The methyl ester functionality can be retained for selective C-terminal strategies or transformed into an activated carboxylate equivalent to enable coupling with protected amino partners under peptide synthesis conditions. The defined trans stereochemistry at the amino acid framework can be carried through into peptide backbones to support stereochemical control in sequence-defined analogs. Downstream, the resulting protected ACHC-containing residues can be incorporated into linear peptides, cyclic scaffolds, or constrained peptidomimetics where stereodefined side-chain geometry matters for structure-function studies.

2. Side-Chain Functionalization

H-1,4-trans-ACHC-OMe*HCl is suitable for side-chain functionalization and derivatization programs because the ACHC framework provides a stereochemically constrained platform for subsequent chemical transformations. The ester group enables controlled conversion to amide, acid, or other activated forms, while the salt-protonated amine can be managed through protection/deprotection strategies to direct selective reactivity during multistep synthesis. The trans stereochemistry can influence the stereochemical outcome of functional group installation steps, including formation of substituted derivatives intended for conformational tuning. Resulting functionalized ACHC derivatives can be used to generate libraries of amino acid analogs for chemical biology research, scaffold diversification, and structure-activity relationship studies.

3. Chiral Building Block Development

H-1,4-trans-ACHC-OMe*HCl functions as a chiral amino acid intermediate for preparing stereochemically defined building blocks used in synthetic organic chemistry and medicinal chemistry-oriented synthesis. The combination of a defined trans configuration and an amino ester handle allows conversion into N-protected, peptide-coupling-ready forms such as protected methyl esters or activated acid derivatives. The hydrochloride salt form can facilitate handling and salt-stable storage while enabling consistent downstream protection chemistry for reproducible stereochemical incorporation. Chiral building block derivatives derived from this compound can then be employed in the synthesis of peptidomimetics, constrained amino acid residues, and stereodefined fragments for fragment-based molecular design.

4. Pharmaceutical Intermediate Preparation

H-1,4-trans-ACHC-OMe*HCl can be applied in pharmaceutical intermediate preparation where amino acid ester chemistry and stereochemical fidelity are required for downstream manufacturing routes. The methyl ester and amino functionalities are compatible with industrially scalable protection-group strategies that enable conversion to coupling-ready intermediates and controlled formation of amide linkages in later steps. The trans-configured stereocenter can be carried into final intermediate structures used for peptide-like or peptidomimetic motifs, supporting consistent stereochemical profiles across batch synthesis. Industrially, the compound's role as a chiral, functionalized amino acid ester makes it suitable for process chemistry sequences that require reliable intermediate generation for fine chemical production.

5. Analytical Standards And Method Development

H-1,4-trans-ACHC-OMe*HCl is applicable to analytical research and method development as a stereochemically defined reference material for monitoring amino acid derivative synthesis and peptide coupling intermediates. The presence of a chiral amino ester hydrochloride provides a well-defined chemical identity that can be used to calibrate chromatographic or spectrometric workflows targeting ACHC-containing species. The ester and salt forms can help distinguish precursor, protected intermediate, and hydrolysis or conversion states during process monitoring and impurity profiling. Analytical standards prepared from this compound can support quality-by-design investigations for amino acid derivative manufacturing, including verification of stereochemical integrity and functional group conversion during synthesis.

1. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling